Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model ; volume:14 ; number:1 ; day:27 ; month:3 ; year:2019 ; pages:1-13 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (27.3.2019), 1-13, 12.2019

Creator: Green, Claudia
Sydow, Astrid
Vogel, Stefanie
Anglada-Huguet, Marta
Wiedermann, Dirk
Mandelkow, Eckhard
Mandelkow, Eva-Maria
Hoehn, Mathias

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13024-019-0316-6

URN: urn:nbn:de:101:1-2019041823114228369537

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Green, Claudia
Sydow, Astrid
Vogel, Stefanie
Anglada-Huguet, Marta
Wiedermann, Dirk
Mandelkow, Eckhard
Mandelkow, Eva-Maria
Hoehn, Mathias
SpringerLink (Online service)

Other Objects (12)

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

Emotional prosody recognition is impaired in Alzheimer’s disease

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study

Impaired Functional Criticality of Human Brain during Alzheimer’s Disease Progression

Related objects

Reset password